NCT03630991 2026-03-02Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing ChemotherapyM.D. Anderson Cancer CenterPhase 1 Recruiting58 enrolled
NCT07166419 2025-12-24Anti-CD19/20/22 Chimeric Antigen Receptor T Cells (TriCAR19.20.22 T Cells) for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, and Chronic Lymphocytic LeukemiaOhio State University Comprehensive Cancer CenterPhase 1 Recruiting24 enrolled
NCT03934372 2025-12-17Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid TumorsIncyte CorporationPhase 1/2 Recruiting70 enrolled
NCT03589729 2025-11-20Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood CancersM.D. Anderson Cancer CenterPhase 2 Recruiting100 enrolled
NCT04260022 2025-11-05Study of HQP1351 in Subjects With Refractory CML and Ph+ ALLAscentage Pharma Group Inc.Phase 1 Recruiting242 enrolled
NCT00935090 2025-07-083'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With CancerBarbara Ann Karmanos Cancer InstituteRecruiting